7 Scientific Writing Mistakes That Delay DCGI Approval in India
Obtaining DCGI approval is a critical step in pharmaceutical product development. However, many companies face delays because of poor scientific writing in India and incomplete regulatory documentation. Errors such as inconsistent data, weak clinical summaries, and formatting issues can lead to regulatory queries and extended approval timelines. In this article, Frontro Pharma explains the most […]
